-transparent.png){kind=logo}
Influenza viruses are etiological agents of deadly flu that continue to pose global health threats, and have caused global pandemics that killed millions of people worldwide. The availability of neuraminidase inhibitors and attenuated vaccines improves our ability to defend against influenza, but their benefits can be significantly limited by drug-resistance and virus mutations. Nucleic acid-based drugs may represent a promising class of antiviral agents that could play a role in the prevention and treatment of influenza. Efficacy studies in animals have shown that ds RNA, such as poly ICLC can provide effective and broad-spectrum prophylaxis against lethal challenges against various strains of influenza A virus. Furthermore, similar level of antiviral protection in mice can be provided by using short fragments of oligonucleotides that induce antiviral immunity. Finally, influenza virus expression can also be specifically inhibited or suppressed using antisense oligonucleotides that bind to viral mRNA encoding key viral proteins. The versatility and potency of nucleic acid-based drugs make them potential drug candidates for used in seasonal or pandemic influenza situations.
J P Wong, and
M E Christopher, and
A M Salazar, and
R M K Dale, and
L-Q Sun, and
M Wang
June 2007,
Recent patents on anti-infective drug discovery,
J P Wong, and
M E Christopher, and
A M Salazar, and
R M K Dale, and
L-Q Sun, and
M Wang
January 2015,
Future medicinal chemistry,
J P Wong, and
M E Christopher, and
A M Salazar, and
R M K Dale, and
L-Q Sun, and
M Wang
April 2006,
Current opinion in molecular therapeutics,
J P Wong, and
M E Christopher, and
A M Salazar, and
R M K Dale, and
L-Q Sun, and
M Wang
August 2016,
The Journal of general virology,
J P Wong, and
M E Christopher, and
A M Salazar, and
R M K Dale, and
L-Q Sun, and
M Wang
July 2008,
Emerging infectious diseases,
J P Wong, and
M E Christopher, and
A M Salazar, and
R M K Dale, and
L-Q Sun, and
M Wang
February 2023,
Letters in applied microbiology,
J P Wong, and
M E Christopher, and
A M Salazar, and
R M K Dale, and
L-Q Sun, and
M Wang
February 2015,
Microbes and infection,
J P Wong, and
M E Christopher, and
A M Salazar, and
R M K Dale, and
L-Q Sun, and
M Wang
December 2015,
The Medical letter on drugs and therapeutics,
J P Wong, and
M E Christopher, and
A M Salazar, and
R M K Dale, and
L-Q Sun, and
M Wang
January 2014,
The Medical letter on drugs and therapeutics,
J P Wong, and
M E Christopher, and
A M Salazar, and
R M K Dale, and
L-Q Sun, and
M Wang
January 2015,
JAMA,
